Heidi Cuthbert

Riskified (NYSE:RSKD) delivered a strong fourth-quarter performance, posting a net income of $5.8 million, or 4 cents per share.

Asian equity markets suffered a brutal sell-off on March 4 as an intensifying conflict in the Middle East sparked fears of a global energy shock.

Nuchev (ASX:NUC) has entered into a pivotal distribution agreement with H&S Global (Au), marking a fundamental shift in the company's commercial strategy.

Terrain Minerals (ASX:TMX) completed an extensive 7,739-metre drilling program at its 100% owned Smokebush Gold-Silver Project.

China has surpassed Japan to become Australia's largest source of new vehicles in for the first time in a single month.

Rincon Resources (ASX:RCR) entered into a binding agreement to dispose of its Laverton assets in Western Australia's Eastern Goldfields.

Chatham Lodging Trust (NYSE:CLDT), a real estate investment trust (REIT) focused on upscale extended-stay and select-service hotels, announced a major strategic expansion on Wednesday.

Ocugen (NASDAQ:OCGN), a Malvern, Pennsylvania-based clinical-stage biotechnology company developing modifier gene therapies for ophthalmic and other diseases, on Wednesday reported financial results for the fourth quarter and full year ended December 31, 2025, alongside a business update highlighting progress across its three lead modifier gene therapy programs.

EyePoint Pharmaceuticals (NASDAQ:EYPT) entered a critical catalyst year on Wednesday, reporting full-year 2025 results and a clinical roadmap that places its lead candidate, DURAVYU, on track for its first pivotal Phase 3 readout in just months.

European Wax Center (NASDAQ: EWCZ) announced a dip in annual profits and revenue for fiscal 2025 on Wednesday, providing what is likely one of its final public financial updates as the company prepares to go private under a $330 million agreement with General Atlantic.